Robert Plenge

Robert Plenge

Chief Tech/Sci/R&D Officer at BRISTOL-MYERS SQUIBB COMPANY

Net worth: 2 M $ as of 30/08/2026

55 year
Health Technology
Consumer Services
Health Services

Profile

Dr. Robert M.
Plenge
is an Independent Director at BioMarin Pharmaceutical, Inc. and a Chief Research Officer, EVP & Head-Research at Bristol Myers Squibb Co. He is on the Board of Directors at BioMarin Pharmaceutical, Inc. and PhRMA Foundation.
Dr. Plenge was previously employed as a VP-Translational Development & Research by Celgene Corp., a Vice President & Head-Translational Medicine by Merck & Co., Inc., an Associate Member-Broad Institute by The Brigham & Women's Hospital, Inc., and an Associate Member by The Broad Institute, Inc. He also served on the board at Translate Bio, Inc. He received his undergraduate degree from the University of California San Diego and a doctorate degree from Case Western Reserve University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/03/2026 24,754 ( 0% ) 2 M $ 30/08/2026
09/09/2026 6,140 ( 0% ) 400 512 $ 30/08/2026

Robert Plenge active positions

CompaniesPositionStart
BRISTOL-MYERS SQUIBB COMPANY Chief Tech/Sci/R&D Officer 31/10/2019
BIOMARIN PHARMACEUTICAL INC. Director/Board Member 09/09/2026
Director/Board Member -
Director/Board Member -

Former positions of Robert Plenge

CompaniesPositionEnd
TRANSLATE BIO, INC. Director/Board Member 13/09/2021
MERCK & CO., INC. Corporate Officer/Principal 30/04/2017
Corporate Officer/Principal 31/12/2012
Corporate Officer/Principal 31/12/2012
CELGENE Chief Tech/Sci/R&D Officer -
See the detail of Robert Plenge's experience

Training of Robert Plenge

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology